WO2017178174A1 - Methods of treatment of cholestasis and fibrosis,https://www.google.com/patents/WO2017178174A1
CN104188994A - Application of swertiamarin serving as drug for ...,https://www.google.com/patents/CN104188994A?cl=en
EP0893949B1 - Use of antioxidant agents to treat cholestatic liver ...,https://www.google.com/patents/EP0893949B1?cl=ko
EP1511379A1 - Prevention or treatment of abnormal lipoprotein ...,https://www.google.com/patents/EP1511379A1?cl=no
WO2017085351A1 - Retinoic acid derivatives for the treatment of ...,https://www.google.com/patents/WO2017085351A1?cl=en
EP0501293A1 - Use of S-adenosyl-L-methionine in the treatment of ...,http://www.google.com/patents/EP0501293A1?cl=enGo
EP3119384A1 - Treatment of intrahepatic cholestatic diseases ...,http://www.google.com/patents/EP3119384A1?cl=en
CA2061536A1 - Use of s-adenosyl-l-menthionine in the treatment of ...,https://google.com/patents/CA2061536A1?cl=pt-pt
EP2770990A4 - Bile acid recycling inhibitors for treatment of ...,https://www.google.com/patents/EP2770990A4?cl=el
WO2017085119A1 - Method and assay for the assessment of a ...,http://www.google.com/patents/WO2017085119A1?cl=no
